Company profile for Orgenesis

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Orgenesis is a vertically-integrated biopharmaceutical company with unique expertise and experience in cell therapy development and manufacturing. The Company's MaSTherCell subsidiary is a global Contract Development and Manufacturing Organization (CDMO). Through MaSTherCell, Orgenesis is able to deliver optimized process industrialization capacities to cell therapy companies, and speed up the arrival of these therapies onto ...
Orgenesis is a vertically-integrated biopharmaceutical company with unique expertise and experience in cell therapy development and manufacturing. The Company's MaSTherCell subsidiary is a global Contract Development and Manufacturing Organization (CDMO). Through MaSTherCell, Orgenesis is able to deliver optimized process industrialization capacities to cell therapy companies, and speed up the arrival of these therapies onto the market. MaSTherCell's customers include many of the world's leading pharmaceutical and biotech companies, as well as research institutions and hospitals involved in cutting edge cell therapy.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
20271 Goldenrod Lane Germantown, MD 20876
Telephone
Telephone
480-659-6404
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/orgenesis-inc-announces-acquisition-of-certain-neurocords-llc-assets-s-996914

ACCESSWIRE
06 Mar 2025

https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/orgenesis-secures-up-to-5-million-equity-investment-from-williamsburg--974899

ACCESSWIRE
28 Jan 2025

https://www.contractpharma.com/contents/view_breaking-news/2023-05-18/orgenesis-sctbio-partner-to-expand-pocare-sites-in/?widget=listSection

CONTRACT PHARMA
18 May 2023
Orgenesis in tie-up with Israeli technology provider
Orgenesis in tie-up with Israeli technology provider

01 Sep 2021

// Jane Byrne BIOPHARMA-REPORTER

https://www.biopharma-reporter.com/Article/2021/09/01/Maximizing-the-potency-of-autologous-cell-lines-Orgenesis-in-tie-up-with-Israeli-technology-provider?utm_source=copyright&utm_medium=OnSite&utm_campaign=copyright

Jane Byrne BIOPHARMA-REPORTER
01 Sep 2021

https://seekingalpha.com/pr/18445232-orgenesis-announces-collaboration-agreement-savicell-to-license-and-deploy-immunobiopsy

SEEKINGALPFA
23 Aug 2021

https://www.pharmtech.com/view/orgenesis-and-cure-therapeutics-form-joint-venture-for-cell-and-gene-therapies

PHARMTECH
10 Dec 2020

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty